Among non-ccRCC samples, several genes demonstrated statistically significant differential expression between treatment groups (B3GAT2, CAPN3, MTND1P23, RNU5D-1, SNORD3A, MRPS5, ARF5, MIF, MTATP6P1, and ENSG00000196656; Figure 2C). This evidence concerns the gene MTND1P23 and nonpapillary renal cell carcinoma.